STERIS CORP 4

4 · STERIS CORP · Filed Oct 2, 2013

Form 4

Period: 2013-10-01

SR VP & Grp. Pres., Healthcare

Transactions

Exercise/Conversion
Common Shares, No Par Value
2013-10-01$24.72/sh+8,000$197,760→ 29,581 total
Sale
Common Shares, No Par Value
2013-10-01$43.51/sh−8,000$348,076→ 21,581 total
Sale
Common Shares, No Par Value
2013-10-01$43.00/sh−7,500$322,500→ 13,469 total(indirect: See Footnote Below.)
Exercise/Conversion
Employee Stock Option Exercise
2013-10-01−8,000→ 0 total
Exercise: $24.72Exp: 2016-09-12→ Common Shares, No Par Value (8,000 underlying)

Footnotes (6)

[F1]These open market sales of a total of 8,000 Common Shares are pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 5, 2013.
[F2]This represents the average sales price of the shares sold. The actual 30 sales prices ranged from $43.3800 per share to $43.6900 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 30 sales prices.
[F3]19,200 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 4,500 on May 20, 2014, 3,700 on June 1, 2015, 5,000 on May 31, 2016 and 6,000 on May 31, 2017.
[F4]These open market sales of a total of 7,500 Common Shares are pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 10, 2013.
[F5]These shares are held in The Sharon A. Chapman 2007 Amended & Restated Revocable Trust UAD 7/20/2007 for the benefit of the Reporting Person's spouse. The Reporting Person and the Reporting Person's spouse are co-trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
[F6]These options became exercisable as follows: 2,000 on September 12, 2007, 2,000 on September 12, 2008, 2,000 on September 12, 2009 and 2,000 on September 12, 2010.

Documents

1 file